Do gender and race impact the use of antithrombotic therapy in patients with stroke/TIA?
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 15210905.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors examined the relationships between sex and race and antithrombotics prescribed at discharge in the Michigan Medicare population using retrospective medical record abstraction (n = 2,715) for the period January 1, 2001, to June 30, 2001. There were no differences in the use of antithrombotics at discharge by race or sex and no differences in the prescribing of aspirin, warfarin, aspirin/extended release dipyridamole, or clopidogrel by race or sex after adjustment for confounders.
Medical subject headings
- Black or African American
- Fibrinolytic Agents
- Ischemic Attack, Transient
- Stroke
- Thrombolytic Therapy
- White People